Literature DB >> 2139637

Influence of mannitol on the penetration of teicoplanin into infected CSF of experimental Staphylococcus aureus meningitis of rabbits.

G Manquat1, J P Stahl, I Pelloux, M Micoud.   

Abstract

We investigated the influence to mannitol injections on the teicoplanin penetration into CSF in experimental bacterial meningitis of rabbits. Experimental bacterial meningitis was obtained by intracisternal inoculation of 10(7) cfu of methicillin resistant Staphylococcus aureus. The experimental bacterial meningitis was controlled 18 h later by cisternal puncture. At this time (T0) mannitol (solution for injection 20%) was injected (bolus), at a dosage of 3 ml/kg, into the carotid arteria. Immediately after the previous bolus, teicoplanin was administered through the same line over 5 min, at a dosage of 5 mg/kg. Cerebrospinal fluid was obtained 30 min and 2 h after injection was completed, and serum samples were obtained at the same time. Results were (mg/l) in cerebrospinal fluid: (Table; see text) (* p less than 0.05 comparing the two regimens at T0 + 2 h, and comparing regimen teicoplanin + mannitol infusion at T0 + 30 sec and + 2 h). This is very promising for the treatment of methicillin resistant Staphylococcus aureus bacterial meningitits and should support further investigations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139637     DOI: 10.1007/bf01641429

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

Authors:  E A Neuwelt; J Howieson; E P Frenkel; H D Specht; R Weigel; C G Buchan; S A Hill
Journal:  Neurosurgery       Date:  1986-10       Impact factor: 4.654

2.  Poor penetration of teicoplanin into cerebrospinal fluid in patients with bacterial meningitis.

Authors:  J P Stahl; J Croize; M Wolff; J J Garaud; P Leclercq; F Vachon; M Micoud
Journal:  J Antimicrob Chemother       Date:  1987-07       Impact factor: 5.790

3.  Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.

Authors:  E A Neuwelt; J Minna; E Frenkel; P A Barnett; C I McCormick
Journal:  Am J Physiol       Date:  1986-05

4.  Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.

Authors:  E A Neuwelt; P A Barnett; C I McCormick; E P Frenkel; J D Minna
Journal:  Neurosurgery       Date:  1985-09       Impact factor: 4.654

5.  Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits.

Authors:  B A Perkins; L J Strausbaugh
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

6.  Mannitol treatment in experimental Haemophilus influenzae type b meningitis.

Authors:  G A Syrogiannopoulos; K D Olsen; G H McCracken
Journal:  Pediatr Res       Date:  1987-08       Impact factor: 3.756

7.  Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.

Authors:  E A Neuwelt; S I Rapoport
Journal:  Fed Proc       Date:  1984-02

8.  Osmotic blood-brain barrier modification: clinical documentation by enhanced CT scanning and/or radionuclide brain scanning.

Authors:  E A Neuwelt; H D Specht; J Howieson; J E Haines; M J Bennett; S A Hill; E P Frenkel
Journal:  AJR Am J Roentgenol       Date:  1983-10       Impact factor: 3.959

9.  Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening.

Authors:  E A Neuwelt; E Balaban; J Diehl; S Hill; E Frenkel
Journal:  Neurosurgery       Date:  1983-06       Impact factor: 4.654

10.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.